In Tuesday’s Wall Street session, Processa Pharmaceuticals Inc (NASDAQ:PCSA) shares traded at $0.27, up 4.57% from the previous session.
PCSA stock price is now -41.40% away from the 50-day moving average and -74.76% away from the 200-day moving average. The market capitalization of the company currently stands at $1.42M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $8, H.C. Wainwright recently initiated with Buy rating for Processa Pharmaceuticals Inc (NASDAQ: PCSA).
In other news, Yorke Justin W, Director bought 12,400 shares of the company’s stock on Jan 27 ’25. The stock was bought for $9,889 at an average price of $0.80. Upon completion of the transaction, the Director now directly owns 12,400 shares in the company, valued at $3348.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 27 ’25, Chief Executive Officer Ng George K bought 87,200 shares of the business’s stock. A total of $69,542 was incurred on buying the stock at an average price of $0.80. This leaves the insider owning 87,200 shares of the company worth $23544.0. A total of 11.36% of the company’s stock is owned by insiders.
During the past 12 months, Processa Pharmaceuticals Inc has had a low of $0.21 and a high of $3.10. As of last week, the company has a debt-to-equity ratio of 0.04, a current ratio of 1.22, and a quick ratio of 1.22. The fifty day moving average price for PCSA is $0.46096 and a two-hundred day moving average price translates $1.07018 for the stock.
The latest earnings results from Processa Pharmaceuticals Inc (NASDAQ: PCSA) was released for 2024-12-31.
